Publications by authors named "Roger Byhardt"

Claim this Profile
E
Elective lymph node irradiation with intensity-modulated radiotherapy: is conventional dose fractionation necessary?
Meena Bedi, Selim Firat, Vladimir A Semenenko, Christopher Schultz, Patrick Tripp, Roger Byhardt

Int J Radiat Oncol Biol Phys· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute esophagitis and late lung toxicity in concurrent chemoradiotherapy trials in patients with locally advanced non-small-cell lung cancer: analysis of the radiation therapy oncology group (RTOG) database.
Maria Werner-Wasik, Rebecca Paulus, Walter J Curran, Roger Byhardt

Clin Lung Cancer· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, double-blinded, placebo-controlled crossover trial of treating erectile dysfunction with sildenafil after radiotherapy and short-term androgen deprivation therapy: results of RTOG 0215.
Deborah Watkins Bruner, Jennifer L James, Charlene J Bryan, Thomas M Pisansky, Marvin Rotman, Roger Byhardt

J Sex Med· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of comorbidity and age on RTOG study enrollment in Stage III non-small cell lung cancer patients who are eligible for RTOG studies.
Selim Firat, Roger W Byhardt, Elizabeth Gore

Int J Radiat Oncol Biol Phys· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: phase I results of RTOG 0117.
Jeffrey D Bradley, Jennifer Moughan, Mary V Graham, Roger Byhardt, Ramaswamy Govindan

Int J Radiat Oncol Biol Phys· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117.
Jeffrey D Bradley, Kyounghwa Bae, Mary V Graham, Roger Byhardt, Ramaswamy Govindan

J Clin Oncol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does response to induction chemotherapy predict survival for locally advanced non-small-cell lung cancer? Secondary analysis of RTOG 8804/8808.
Mary Frances McAleer, Jennifer Moughan, Roger W Byhardt, James D Cox, William T Sause

Int J Radiat Oncol Biol Phys· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The importance of protein kinase A in prostate cancer: relationship to patient outcome in Radiation Therapy Oncology Group trial 92-02.
Alan Pollack, Kyounghwa Bae, Li-Yan Khor, Tahseen Al-Saleem, M Elizabeth Hammond, Roger W Byhardt

Clin Cancer Res· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MDM2 and Ki-67 predict for distant metastasis and mortality in men treated with radiotherapy and androgen deprivation for prostate cancer: RTOG 92-02.
Li-Yan Khor, Kyounghwa Bae, Rebecca Paulus, Tahseen Al-Saleem, M Elizabeth Hammond, Roger W Byhardt

J Clin Oncol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinically meaningful differences in patient-reported outcomes with amifostine in combination with chemoradiation for locally advanced non-small-cell lung cancer: an analysis of RTOG 9801.
Linda Sarna, Suzanne Swann, Corey Langer, Maria Werner-Wasik, Nicos Nicolaou, Roger Byhardt

Int J Radiat Oncol Biol Phys· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microvessel density >or=60 does not predict for outcome after radiation treatment for locally advanced head and neck squamous cell carcinoma: results of a correlative study from the Radiation Therapy Oncology Group (RTOG) 90-03 Trial.
Douglas P Calvin, M E Hammond, Thomas F Pajak, Andy M Trotti, Ruby F Meredith, Roger W Byhardt

Am J Clin Oncol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality assurance methods for the first Radiation Therapy Oncology Group permanent prostate implant protocol.
Michael T Gillin, Bernadine F Dunning, Colleen A Lawton, W Dennis Foley, Roger W Byhardt

Brachytherapy· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age is independent of comorbidity influencing patient selection for combined modality therapy for treatment of stage III nonsmall cell lung cancer (NSCLC).
Selim Firat, Adam Pleister, Roger W Byhardt, Elizabeth Gore

Am J Clin Oncol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non-small-cell lung carcinoma: analysis of the Radiation Therapy Oncology Group (RTOG) experience.
Mitchell Machtay, Chuanchieh Hsu, Ritsuko Komaki, William T Sause, R Suzanne Swann, Roger W Byhardt

Int J Radiat Oncol Biol Phys· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study.
David S Ettinger, Brian A Berkey, Ross A Abrams, James Fontanesi, Mitchell Machtay, Roger W Byhardt

J Clin Oncol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of thoracic radiation dose escalation with concurrent chemotherapy for patients with limited small-cell lung cancer: Report of Radiation Therapy Oncology Group (RTOG) protocol 97-12.
Ritsuko Komaki, R Suzanne Swann, David S Ettinger, Bonnie S Glisson, Alan B Sandler, Roger W Byhardt

Int J Radiat Oncol Biol Phys· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01.
Benjamin Movsas, Charles Scott, Corey Langer, Maria Werner-Wasik, Nicos Nicolaou, Roger Byhardt

J Clin Oncol· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of regional nodal radiotherapy (dose/volume) on regional progression and survival in unresectable non-small cell lung cancer: an analysis of RTOG data.
Bahman Emami, Nena Mirkovic, Charles Scott, Roger Byhardt, Mary V Graham

Lung Cancer· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do "elderly fit" patients have less comorbidity?
Selim Firat, Elizabeth Gore, Roger W Byhardt

Int J Radiat Oncol Biol Phys· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies. Radiation Therapy Oncology Group.
Selim Firat, Roger W Byhardt, Elizabeth Gore

Int J Radiat Oncol Biol Phys· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small-cell lung cancer with spread to mediastinal lymph nodes (N2); final report of RTOG 89-01. Radiation Therapy Oncology Group.
David W Johnstone, Roger W Byhardt, David Ettinger, Charles B Scott

Int J Radiat Oncol Biol Phys· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer.
Selim Firat, Michael Bousamra, Elizabeth Gore, Roger W Byhardt

Int J Radiat Oncol Biol Phys· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis